Companies/US/STE

STERIS PLC

Income flow

Annual
STE 10-K Income StatementPeriod 2025-03-31Source 10-K
Healthcare$2BHealthcare Segment$2BApplied Sterilization Technologies$607MLife Science Member$317MRevenue$5B+6% Y/YGross profit$2B+8% Y/YCost of revenue$3BOperating profit$867M+4% Y/YOperating expenses$2BNet profit$615M+63% Y/YTax$185MSG&A$1BR&D & other$202M

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-03-31 · 10-K · USD
By activity
By activity$9.3B
  • Healthcare$3.9B41.5%
  • Healthcare Segment$3.9B41.5%
  • Applied Sterilization Technologies$1.0B11.1%
  • Life Science Member$542M5.8%
By geography
By geography$5.5B
  • United States$4.0B73.4%
  • Otherforeignlocations$1.3B24.6%
  • IE$107M2.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.18%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.0.92%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).2.52PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.30.8%Shares outTotal shares currently outstanding (issued and not retired).97.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).97.1M
Dividend calendar
Ex-dividend
2026-09-04
Pay date
2026-09-25
Last cash
0.69 · 2026-09-04
Stock splits
  1. 2:11998-08-25

Valuation

Trailing PE 36.1 (2025-03-31)PE trend

Fiscal PE1

PeriodEPSClosePE
2025-03-316.2223.6136.1

PE = stored close ÷ as-filed diluted EPS (annual 10-K / 20-F). Not a vendor PE series.